When you start to feel shitty about the Stock price!!Go back and read the Technology MarketWatch Journal and remind yourself why your hear!..........How big will this get (ONLY ANDRE KNOWS)? The answer is 'we just don't know' (MAYBE THE ANALYST WILL LET US IN ON THE SECRET), but there are numerous indicators ADK.V is going on a massive run (TO THE BASEMENT UNTIL THE NEXT PR)............ DIAGNOS' test is painless (WATCHING THE STOCK PRICE IS NOT) and quick, generally taking 2 - 3 minutes maximum.......... Having artificial intelligence in the loop to take care of a very demanding interpretation task that requires a high degree of proficiency, consistency, and accuracy 24/7 is a great benefit to specialists (MAYBE WE SHOULD LET THE ARTIFICIAL INTELLIGENCE PROMOTE THE STOCK). DIAGNOS' software can operate at the same high level all day long (WHERE THE CEO CANNOT), where as traditional methods rely upon alertness of humans (ANDRE WAKE UP!). Government involvement with DIAGNOS is the big prize for shareholders; when (WHEN, WHEN, WHEN) key news is announced, we anticipate it will act as a major catalyst that will supplant all current projections and cause a dramatic upside revaluation (OR MAYBE AN UPCHUCK) in share price, well above what is being discussed here today (OR MAYBE NOT)...... Medical Software Has the Mechanics of a Great Business....... When (WHEN, WHEN,) mature (WE MAY SEE SOME REVENUE NUMBERS), DIAGNOS promises to provide investors with a steady stream of recurring (HEADACHES) revenues! While DIAGNOS has a disruptive healthcare technology that looks poised to become a robust business (LOOKS CAN BE DECEIVING), valuing the Company at such an early stage of adoption for its technology and business model is challenging, especially with the Company only this fiscal Q3 (ending December-2016) demonstrating a turn to profitability (WE WILL GIVE THEM THAT). An analysis of qualitative factors provides further support that the shares are due for significant upward revaluation (NOT BEFORE A RUN TO THE BASEMENT). In contrast to some other names in the healthcare sector, DIAGNOS' management has been more interested in running the business than promoting the stock (REALLY I DIDNT NOTICE WITH ALL THE PRs WE HAD THIS WEEK). With the Company's turn to profitability closing out 2016 and a ramp-up of patient tests on tap, more attention is headed the Company's way (RIGHT NOW NOT IN A GOOD WAY), and we expect management will dedicate more resources on responsibly relaying its story to potential investors (OR WE MAY HAVE TO PULL SOME TEETH TO GET REVENUE NUMBERS OUT OF THE CEO). ............Just a little humour to brighten up your day..........Like Dr Evil said ...... Throw us a Fricken Bone here would ya Andre!!!!